Published in J Bacteriol on May 01, 1985
Bacteriocins of gram-positive bacteria. Microbiol Rev (1995) 7.68
Nisin, a peptide antibiotic: cloning and sequencing of the nisA gene and posttranslational processing of its peptide product. J Bacteriol (1989) 3.00
Biosynthesis of the lantibiotic nisin: genomic organization and membrane localization of the NisB protein. Appl Environ Microbiol (1992) 2.18
Mode of action of the staphylococcinlike peptide Pep 5: voltage-dependent depolarization of bacterial and artificial membranes. J Bacteriol (1988) 2.10
Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J Bacteriol (1987) 1.82
Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect Immun (1996) 1.79
Genes involved in immunity to the lantibiotic nisin produced by Lactococcus lactis 6F3. Appl Environ Microbiol (1995) 1.77
Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother (1991) 1.69
Genes involved in self-protection against the lantibiotic subtilin produced by Bacillus subtilis ATCC 6633. Appl Environ Microbiol (1994) 1.64
Permeation of bacterial cells, permeation of cytoplasmic and artificial membrane vesicles, and channel formation on lipid bilayers by peptide antibiotic AS-48. J Bacteriol (1991) 1.49
Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci. Infect Immun (2010) 1.48
Purification and amino acid composition of peptide antibiotic AS-48 produced by Streptococcus (Enterococcus) faecalis subsp. liquefaciens S-48. Antimicrob Agents Chemother (1989) 1.32
Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. PLoS One (2009) 1.14
Pumilicin 4, a novel bacteriocin with anti-MRSA and anti-VRE activity produced by newly isolated bacteria Bacillus pumilus strain WAPB4. Curr Microbiol (2007) 1.13
Mechanisms of antibacterial action of tachyplesins and polyphemusins, a group of antimicrobial peptides isolated from horseshoe crab hemocytes. Antimicrob Agents Chemother (1992) 1.10
Effect of peptide AS-48 on Enterococcus faecalis subsp. liquefaciens S-47. Antimicrob Agents Chemother (1989) 0.99
The antimicrobial effect of a structural variant of subtilin against outgrowing Bacillus cereus T spores and vegetative cells occurs by different mechanisms. Appl Environ Microbiol (1993) 0.99
Staphylococcin 1580 is identical to the lantibiotic epidermin: implications for the nature of bacteriocins from gram-positive bacteria. Appl Environ Microbiol (1994) 0.96
Effect of lysozyme on glucose fermentation, cytoplasmic pH, and intracellular potassium concentrations in Streptococcus mutans 10449. Infect Immun (1991) 0.88
Killing of staphylococci by θ-defensins involves membrane impairment and activation of autolytic enzymes. Antibiotics (Basel) (2014) 0.80
A conserved streptococcal membrane protein, LsrS, exhibits a receptor-like function for lantibiotics. J Bacteriol (2014) 0.79
Colicins and other bacteriocins with established modes of action. Annu Rev Microbiol (1982) 3.74
Changes of total water and sucrose space accompanying induced ion uptake or phosphate swelling of rat liver mitochondria. Biochem J (1968) 2.79
New procedure for the isolation of membrane vesicles of Bacillus subtilis and an electron microscopy study of their ultrastructure. J Bacteriol (1973) 2.44
Production, purification and chemical properties of an antistaphylococcal agent produced by Staphylococcus epidermidis. J Gen Microbiol (1981) 2.20
Colicin V-treated Escherichia coli does not generate membrane potential. J Bacteriol (1984) 1.97
Voltage-dependent trans-bilayer orientation of melittin. J Biol Chem (1982) 1.86
Mode of action of the staphylococcin-like peptide Pep 5 and culture conditions effecting its activity. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 1.58
Interaction of Staphylococcus aureus delta-lysin with phospholipid monolayers. Biochemistry (1982) 1.09
Energy requirements for the action of staphylococcin 1580 in Staphyloccus aureus. Biochim Biophys Acta (1978) 1.08
Plasmid involvement in production of and immunity to the staphylococcin-like peptide Pep 5. J Gen Microbiol (1984) 1.07
Dependence of the activity of colicin E1 in artificial membrane vesicles on pH, membrane potential, and vesicle size. J Biol Chem (1984) 1.06
Effects of staphylococcin 1580 on cells and membrane vesicles of Bacillus subtilis W23. Biochim Biophys Acta (1978) 0.88
Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science (1999) 5.30
Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob Agents Chemother (1985) 3.83
Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem (2000) 3.65
Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol Microbiol (1998) 2.69
Production, purification and chemical properties of an antistaphylococcal agent produced by Staphylococcus epidermidis. J Gen Microbiol (1981) 2.20
Mode of action of the staphylococcinlike peptide Pep 5: voltage-dependent depolarization of bacterial and artificial membranes. J Bacteriol (1988) 2.10
Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles. Biochemistry (1995) 2.10
The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob Agents Chemother (1998) 2.06
Interaction of the pore forming-peptide antibiotics Pep 5, nisin and subtilin with non-energized liposomes. FEBS Lett (1989) 1.95
Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur J Clin Microbiol Infect Dis (1999) 1.87
Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch Microbiol (1989) 1.85
Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J Bacteriol (1987) 1.82
Induction of autolysis of staphylococci by the basic peptide antibiotics Pep 5 and nisin and their influence on the activity of autolytic enzymes. Arch Microbiol (1985) 1.81
Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect Immun (1996) 1.79
Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic. Mol Microbiol (1996) 1.71
The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. Eur J Biochem (1997) 1.59
Mode of action of the staphylococcin-like peptide Pep 5 and culture conditions effecting its activity. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 1.58
The peptide antibiotic subtilin acts by formation of voltage-dependent multi-state pores in bacterial and artificial membranes. Eur J Biochem (1989) 1.54
Protein engineering of lantibiotics. Antonie Van Leeuwenhoek (1996) 1.54
Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism? Antimicrob Agents Chemother (1995) 1.52
Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation. Eur J Biochem (1995) 1.50
Structural similarities of the staphylococcin-like peptide Pep-5 to the peptide antibiotic nisin. Antimicrob Agents Chemother (1985) 1.48
Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids. Eur J Biochem (1990) 1.40
Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol (1998) 1.29
Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147. J Biol Chem (1999) 1.29
Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl Environ Microbiol (1998) 1.28
Posttranslationally modified bacteriocins--the lantibiotics. Biopolymers (2000) 1.27
Immunity to lantibiotics. Antonie Van Leeuwenhoek (1996) 1.24
Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5. Appl Environ Microbiol (1996) 1.18
Construction of an expression system for engineering of the lantibiotic Pep5. Appl Environ Microbiol (1994) 1.16
Cloning, sequencing and production of the lantibiotic mersacidin. FEMS Microbiol Lett (1995) 1.15
Purification and characterization of EpiD, a flavoprotein involved in the biosynthesis of the lantibiotic epidermin. J Bacteriol (1992) 1.14
Producer immunity towards the lantibiotic Pep5: identification of the immunity gene pepI and localization and functional analysis of its gene product. Appl Environ Microbiol (1994) 1.14
Elucidation of the structure of SA-FF22, a lanthionine-containing antibacterial peptide produced by Streptococcus pyogenes strain FF22. Eur J Biochem (1994) 1.14
Interaction of the staphylococcin-like peptide Pep 5 with cell walls and isolated cell wall components of Gram-positive bacteria. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 1.10
Plasmid involvement in production of and immunity to the staphylococcin-like peptide Pep 5. J Gen Microbiol (1984) 1.07
Lantibiotics--unusually modified bacteriocin-like peptides from gram-positive bacteria. Zentralbl Bakteriol (1993) 1.05
Identification and analysis of a gene encoding a Fur-like protein of Staphylococcus epidermidis. FEMS Microbiol Lett (1996) 1.03
New insights into the mechanism of action of lantibiotics--diverse biological effects by binding to the same molecular target. J Antimicrob Chemother (2000) 1.02
Molecular analysis of expression of the lantibiotic pep5 immunity phenotype. Appl Environ Microbiol (1999) 1.02
Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7. Eur J Biochem (1995) 1.02
The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7. Antonie Van Leeuwenhoek (1996) 1.00
The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22. Eur J Biochem (1994) 0.96
Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene. Infect Immun (1999) 0.95
Lantibiotic-mediated anti-lactobacillus activity of a vaginal Staphylococcus aureus isolate. FEMS Microbiol Lett (1992) 0.91
Sequence analysis by NMR spectroscopy of the peptide lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Eur J Biochem (1995) 0.90
Mechanism of action and limited cross-resistance of new lipopeptide MX-2401. Antimicrob Agents Chemother (2011) 0.90
Molecular characterisation of aureocin A70, a multi-peptide bacteriocin isolated from Staphylococcus aureus. J Mol Biol (2001) 0.89
Purification and partial characterization of a murein hydrolase, millericin B, produced by Streptococcus milleri NMSCC 061. Appl Environ Microbiol (2000) 0.88
Effects of the lantibiotic mersacidin on the morphology of staphylococci. Zentralbl Bakteriol (1996) 0.87
Malic enzyme of chromatium vinosum. Arch Microbiol (1980) 0.86
The genetics of lantibiotic biosynthesis. Bioessays (1995) 0.85
GIS-supported investigation of a nosocomial Salmonella outbreak. Int J Hyg Environ Health (2000) 0.85
Effect of leader peptide mutations on biosynthesis of the lantibiotic Pep5. FEMS Microbiol Lett (1997) 0.84
Isolation and mode of action of a staphylococcin-like substance active against gram-positive and gram-negative bacteria. J Gen Microbiol (1984) 0.82
Unique peptide modifications involved in the biosynthesis of lantibiotics. Trends Biotechnol (1995) 0.82
Carnocin UI49, a potential biopreservative produced by Carnobacterium piscicola: large scale purification and activity against various gram-positive bacteria including Listeria sp. Int J Food Microbiol (1993) 0.82
Purification and properties of LIQ 4, an antibacterial substance produced by Streptococcus faecalis var. liquefaciens K4. J Gen Microbiol (1985) 0.81
Influence of cationic peptides on the activity of the autolytic endo-beta-N-acetylglucosaminidase of Staphylococcus simulans 22. FEMS Microbiol Lett (1989) 0.81
Isolation of a new epidermin variant from two strains of Staphylococcus epidermidis--frequency of lantibiotic production in coagulase-negative staphylococci. Zentralbl Bakteriol (1996) 0.78
Antibacterial activities of Candida yeasts. Partial purification and characterization of the active substance of Candida guilliermondii. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 0.77
Lytic activities, protein profiles and morphologic characteristics of new bacteriophages isolated from canine and human Staphylococcus aureus strains. Zentralbl Veterinarmed B (1992) 0.75
[Infantile Campylobacter enteritis (author's transl)]. Klin Padiatr (1981) 0.75
[Extent of bacterial contamination is a derminant fur microvascular damage in soft tissue infection]. Langenbecks Arch Chir Suppl Kongressbd (1998) 0.75